Score Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Breast Cancer Risk Profiling Technology: Digistain is a digital solution for cancer grading and prognosis, approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA). It offers a rapid, affordable, and AI-enabled solution to predict the likelihood of post-surgery breast cancer recurrence. This technology is designed to prevent breast cancer patients from undergoing unnecessary chemotherapy.

Get latest articles and stories on Business at LatestLY. New Delhi [India], September 28: Doceree, the leading global network of physician-only platforms for programmatic messaging, today announced a USD 35 million Series B round led by Creaegis, the leading digital and technology investment firm. Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round. Business News | Doceree Raises USD 35 Million in Series B Funding, Led by Creaegis with Participation from Eight Roads Ventures and F-Prime Capital.

Equipped with cutting-edge technology and staffed by a team of highly skilled professionals

/PRNewswire/ -- Spry, an end-to-end patient and practice management SaaS platform for physical therapists, today announced that it has successfully completed a...

With the HBsAg Next Qualitative Solution, laboratories can now better detect, analyze the infection and reduce the risks of undetected virus, have a consistent detection of all HBV genotypes and...